Feverweed (Eryngium campestre)

Feverweed (Eryngium campestre) is a European thistle-like herb whose bioactive saponins, flavonoids, and phenolic acids drive its documented antimicrobial and antioxidant effects. These compounds appear to inhibit bacterial cell-wall synthesis and scavenge reactive oxygen species, underpinning its traditional use in European herbal medicine.

Origin & History

Eryngium campestre, commonly known as feverweed, is a perennial herb native to Europe, the Caucasus, and North Africa. The primary medicinal part, its root, is harvested in autumn from plants that are at least two years old.

Historical & Cultural Context

In European folk medicine, feverweed has been used for respiratory and urinary conditions, as well as gout and rheumatic ailments. It is also employed in Turkish folk remedies as a hypoglycemic agent and antidote.

Health Benefits

• Antimicrobial activity against Gram-positive bacteria (*in vitro* study)[3].
• Antioxidant effects in diabetic rat models, reducing oxidative stress[4].
• Anti-inflammatory properties observed in animal studies[4].
• Potential antidiabetic effects through modulation of glucose metabolism in animal models[4].
• Traditional use as an antitussive and diuretic, though not clinically validated[1][2].

How It Works

The triterpenoid saponins in Eryngium campestre disrupt bacterial membrane integrity in Gram-positive species by intercalating into lipid bilayers, explaining observed in vitro antimicrobial activity. Phenolic compounds including luteolin and rosmarinic acid inhibit cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, reducing prostaglandin and leukotriene synthesis to produce anti-inflammatory effects. Antidiabetic activity is linked to flavonoid-mediated inhibition of alpha-glucosidase and modulation of GLUT-4 translocation, slowing postprandial glucose absorption and improving peripheral glucose uptake in animal models.

Scientific Research

No human clinical trials or meta-analyses are available for Eryngium campestre. The evidence is limited to in vitro and animal studies, with no PMIDs provided for human subjects.

Clinical Summary

Available evidence for Feverweed is limited to in vitro and rodent studies, with no published randomized controlled trials in humans. In vitro assays demonstrated antimicrobial activity against Gram-positive bacteria including Staphylococcus aureus, though minimum inhibitory concentrations were not consistently reported across studies. Diabetic rat models showed statistically significant reductions in malondialdehyde (MDA) and increases in superoxide dismutase (SOD) activity following Eryngium campestre extract administration, indicating reduced oxidative stress. Anti-inflammatory findings in animal models are promising but cannot be extrapolated to human clinical outcomes without further controlled investigation.

Nutritional Profile

Eryngium campestre (field eryngo/feverweed) has limited formal nutritional analysis in the literature, but the following constituents have been identified and partially quantified: **Bioactive compounds** — saponins (triterpenoid saponins, primarily eryngiumosides, estimated 2–5% dry weight in roots), flavonoids including kaempferol and quercetin glycosides (~0.3–0.8% dry weight in aerial parts), phenolic acids (rosmarinic acid, caffeic acid, chlorogenic acid; total phenolics reported ~15–40 mg GAE/g dry extract in some studies), and essential oils (0.1–0.5% in flowering tops, containing β-caryophyllene, germacrene D, and sabinene as dominant terpenes). **Carbohydrates** — roots are relatively rich in inulin-type fructooligosaccharides and polysaccharides (estimated 10–20% dry weight), contributing to prebiotic potential. **Fiber** — moderate dietary fiber content consistent with Apiaceae family members, though precise values are unreported. **Minerals** — potassium, calcium, and magnesium are present (specific mg/100g values are unreported in literature); historically documented diuretic use may relate to potassium content. **Vitamins** — vitamin C and small amounts of B-group vitamins are presumed based on botanical family characteristics but have not been formally quantified. **Protein and fat** — both are low; aerial parts likely contain <5% crude protein and <2% lipids on a dry weight basis, consistent with other Apiaceae. **Bioavailability notes** — saponins may reduce absorption of co-administered minerals through chelation; flavonoid glycosides require gut microbial hydrolysis for full bioavailability; the essential oil components are volatile and bioavailability is route-dependent. Most quantitative data derives from organic solvent extracts rather than whole-food analysis.

Preparation & Dosage

Traditional dosages include 15 drops of tincture three times daily, and decoctions prepared with 20-50 g of root for various effects. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rosemary, Turmeric, Ginger, Dandelion, Milk Thistle

Safety & Interactions

Eryngium campestre has not been evaluated in formal human safety trials, so a comprehensive adverse-effect profile has not been established. Its saponin content may cause gastrointestinal irritation, including nausea or diarrhea, particularly at higher doses, based on the known properties of triterpenoid saponins. Potential interactions with antidiabetic medications (e.g., metformin, sulfonylureas) are plausible given the herb's glucose-lowering activity in animal models, raising hypoglycemia risk if used concurrently. Pregnant and breastfeeding women should avoid use due to the complete absence of safety data in these populations.